NEXENTIS TECHNOLOGIES INC. Income (Loss) from Continuing Operations, Per Diluted Share
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$13.66 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was -$13.66.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, per diluted share for the quarter ending 2026-03-31 was -$12.10.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was $0.97.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$43.08.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, per diluted share for fiscal 2025 was -$8.11.
- NEXENTIS TECHNOLOGIES INC. income (loss) from continuing operations, per diluted share for fiscal 2024 was -$22.25.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$13.66 10-Q · filed 2026-08-13 | -$25.96 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | -$12.10 10-Q · filed 2026-05-14 | |||||
| 2025-12-31 | -$8.11 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $0.97 10-Q · filed 2025-11-13 | -$8.29 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | -$43.08 10-Q · filed 2026-08-13 | -$0.18 10-Q · filed 2025-08-14 | -$127.27 10-Q · filed 2026-08-13 | -$0.54 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | -$83.12 10-Q · filed 2026-05-14 | |||||
| 2024-12-31 | -$22.25 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |